NCT00872066 - A Study to Assess the Long-term Performance of SmartSet® HV and SmartSet® GHV Bone Cements in Primary Total Hip Replacement | Biotech Hunter

Enrollment

243

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

Rheumatoid ArthritisOsteoarthritisPost-traumatic ArthritisCollagen DisordersAvascular NecrosisTraumatic Femoral FracturesNonunion of Femoral FracturesCongenital Hip DysplasiaSlipped Capital Femoral Epiphysis

Interventions

DEVICE

SmartSet® HV bone cement

A high viscosity bone cement for use in total hip replacement (without gentamicin)

DEVICE

SmartSet® GHV bone cement

A high viscosity bone cement for use in total hip replacement (with gentamicin)

Trial Locations (1)

Unknown

Orthopaedic-traumatology Clinic University Hospital Martin, Martin